GLP-1 injection site reactions

    Short answer

    Mild redness, itching, swelling, bruising or a small lump where you injected are the usual injection site reactions. Labels report them in a minority of people, from under 1% on Ozempic to 6-8% on Zepbound. Most fade without treatment. Spreading redness, warmth, pus, fever or any allergic symptoms need medical attention.

    A pink patch or an itchy bump a day after your weekly shot is common, usually harmless, and still worth understanding. The useful skill is telling an ordinary local reaction from the uncommon ones that need care, and knowing which habits make reactions less likely. This guide covers what counts as a reaction, how often each label reports one, why they happen, how to reduce them, and exactly which signs mean you should call. For pain during the injection itself, see the separate guide on why an injection hurts.

    What counts as an injection site reaction

    In the trials behind these labels, injection site reaction is an umbrella term. The Zepbound label groups bruising, redness (erythema), itching (pruritus), pain, rash and general reaction at the site under it. The Wegovy label lists itching, redness, inflammation, hardening (induration) and irritation. In everyday terms, it is anything that happens to the skin and tissue right where the needle went in.

    What you noticeWhat it usually isWhat it usually does
    Pink or red patchLocal inflammation from the needle and the medicationFades over hours to a few days
    ItchingLocal irritation or a mild skin reactionSettles without treatment; avoid scratching
    BruiseA small blood vessel nicked on the way inChanges color and fades like any bruise
    Small firm bumpSwelling or firmness in the tissue under the skinSoftens over days
    TendernessLocal irritation of the tissueEases day by day rather than building

    When do injection site reactions appear?

    For injected medications in general, a narrative review of injection site pain describes reactions that appear within minutes to a few hours of the injection, and delayed reactions that appear around 24 to 48 hours later. A patch that shows up the next day is therefore not unusual in itself. What matters more is what it does over the following days.

    What about lumps that don't go away?

    A lump that lingers for weeks is a different thing from a day-two bump. The Zepbound vial Instructions for Use warn that injecting the same spot repeatedly can cause lipodystrophy (pits in the skin or thickened skin) and localized cutaneous amyloidosis (skin with lumps), and say not to inject where the skin has pits, is thickened, or has lumps. These build slowly and are prevented by rotation, covered below.

    How often labels report them

    Rates vary more by medication than most people expect. The figures below come from placebo-controlled trials in each label, and they include mild reactions, which is most of them.

    MedicationParticipants with a site reactionPlacebo
    Ozempic (semaglutide)0.2% (placebo-controlled trials)Not stated in this section
    Wegovy injection (semaglutide)1.4% (adult weight-reduction trials)1%
    Mounjaro (tirzepatide)3.2% (pool of placebo-controlled adult trials)0.4%
    Zepbound (tirzepatide)6% to 8%, depending on dose group (two weight-reduction trials)2%

    Why do tirzepatide labels report more reactions?

    The labels do not give a single reason, and trials with different populations and definitions are not perfectly comparable. One pattern they do report: reactions were more frequent in people who developed antibodies to tirzepatide. In the Zepbound trials, 11.3% of people with those antibodies had a site reaction, against 1% of people without them. Mounjaro's label shows the same pattern.

    Is an injection site reaction an allergy?

    Usually not in the dangerous sense. Most are local irritation. The Zepbound label separately reports hypersensitivity reactions, most of them skin reactions such as rash and itching. A serious allergic reaction is a different event entirely, involving swelling of the face, lips, tongue or throat or trouble breathing, and it is covered in the warning signs below.

    From the makers of this guide

    How Pep AI helps you track injection site reactions

    Whether a reaction is a one-off or a pattern is hard to judge from memory. Pep AI keeps the site, the dose and the symptom together, so the pattern is visible.

    1. 01

      Injection-site logging with rotation

      Record where every shot went and see recent sites at a glance, so next week's injection lands on fresh skin rather than last week's patch.

    2. 02

      Injection-site symptoms, rated

      The side-effect tracker has an injection site category. Rate each reaction for severity and watch whether it settles or builds.

    3. 03

      Symptoms on the dose timeline

      Reactions sit on the same timeline as your doses, which makes it easy to tell whether they follow every injection or only some sites.

    4. 04

      Pep Bot for the why

      Ask Pep Bot to explain terms like induration or lipodystrophy. It uses a research-literature retrieval pipeline to explain concepts; it does not give dosing advice.

    Download on the App StoreGet it on Google Play

    Why injection site reactions happen

    Three things meet at an injection site. The needle makes a tiny wound and can nick a small blood vessel, which is where bruising comes from. The medication and its inactive ingredients sit in a small pocket of tissue while they are absorbed, and the body can respond to that with local inflammation. And some people's immune systems react to the medication itself, which is the antibody pattern the tirzepatide labels describe.

    Technique shapes the first two. Injecting into skin that is already bruised or irritated, into the same spot as last week, or through skin still wet with alcohol all add irritation to a site that was going to have a little anyway.

    How to reduce injection site reactions

    Most of what helps comes straight from the Instructions for Use for each pen. None of it is complicated. The value comes from doing it every week, including the weeks you are in a hurry.

    • Rotate every week. The Zepbound and Wegovy instructions allow the same body area each week, but a different spot within it. MedlinePlus suggests keeping sites at least 1 inch apart.
    • Choose healthy skin. The Wegovy instructions say not to inject where skin is tender, bruised, red or hard, and to avoid scars and stretch marks.
    • Clean, then wait. Wipe the site with an alcohol swab (or soap and water, per the Wegovy instructions) and let it dry fully before injecting.
    • Do not touch the site after cleaning, and do not rub it afterward. If there is a drop of blood, press lightly with gauze or a cotton ball.
    • Follow your pen's temperature instructions. Lilly's pen instructions say warming to room temperature is not necessary. Never heat a pen or syringe. Novo Nordisk's prefilled syringe instructions specifically warn against hot water or a microwave.
    • Use a new needle every time on any pen that takes needles. The Ozempic and Wegovy FlexTouch instructions say a new needle reduces the risk of contamination and infection.

    Does rotating injection sites really matter on a weekly shot?

    It matters more than it seems, because a weekly medication still adds up to dozens of injections a year in a few small areas. Our guide to GLP-1 injection sites covers where each site is, and injection site rotation covers how to build a rotation that does not drift back to one favorite spot.

    Can I put ice or cream on an itchy injection site?

    Many people find a cool compress soothing. For creams, antihistamines or anything medicated, ask your pharmacist first, particularly if the reaction keeps coming back. A reaction that recurs every week is worth mentioning to your prescriber even if it is mild, because the pattern itself is useful information.

    Normal healing or a sign to call

    The single most useful test is direction. An ordinary reaction is at its worst early and improves day by day. A reaction that spreads, intensifies or brings on other symptoms is not following that path and needs attention.

    Usually normalCall your healthcare providerGet emergency help
    A small patch of redness that fadesRedness that spreads, or red streaks leading away from the siteSwelling of the face, lips, tongue or throat
    Mild itching that settlesThe site becomes warm, more swollen or more painful over the following daysProblems breathing or swallowing
    A bruise that changes color as it healsPus or other discharge from the siteFainting or feeling dizzy, or a very rapid heartbeat
    A small bump that softens over a few daysFever alongside a site that looks worseA severe rash or severe itching spreading beyond the site

    What does an infected injection site look like?

    MedlinePlus lists redness, swelling, red streaks and fever as signs of infection after an injection. In practice an infected site gets worse over the days after the injection instead of better: warmer, more swollen, more painful, sometimes with pus. Infection after a sterile single-use injection is uncommon, which is exactly why these signs should not be waved off.

    When is a reaction an emergency?

    When the reaction is no longer local. The Ozempic and Zepbound Medication Guides tell you to stop the medication and get medical help right away for swelling of the face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or dizziness, or a very rapid heartbeat. Hives spreading across the body belong in the same category. Call 911 if breathing or swallowing is affected.

    Should I skip my next dose if the last site is still red?

    Inject somewhere else, not skip. A lingering mark is a reason to choose a different site, not by itself a reason to miss a dose. If you are unsure whether the reaction is ordinary, or it is getting worse, call your prescriber before your next injection rather than deciding alone.

    Key takeaways

    • Redness, itching, bruising, mild swelling and small bumps are the usual injection site reactions, and most fade within days.
    • Label rates range from 0.2% on Ozempic to 6-8% on Zepbound, against 2% on placebo in the Zepbound trials.
    • Rotate within an area every week, inject into healthy skin, let alcohol dry, and never heat the pen.
    • Direction is the test: a normal reaction improves; spreading redness, warmth, pus or fever need a call.
    • Swelling of the face, lips, tongue or throat, or trouble breathing, is an emergency. Stop the medication and get help right away.

    See whether it's one site or every site.

    Pep AI logs where each injection went and how the site reacted, on the same timeline as your doses, so patterns show up early. Download Pep AI on iPhone or Android.

    Download on the App StoreGet it on Google Play

    Frequently asked questions

    Keep reading

    Sources

    1. Zepbound (tirzepatide) prescribing information, Eli Lilly / FDA
    2. Mounjaro (tirzepatide) prescribing information, Eli Lilly / FDA
    3. Wegovy (semaglutide) prescribing information, Medication Guide and Instructions for Use, Novo Nordisk / FDA
    4. Ozempic (semaglutide) prescribing information and Medication Guide, Novo Nordisk / FDA
    5. Zepbound (tirzepatide) Medication Guide, Eli Lilly / FDA
    6. Zepbound single-dose vial Instructions for Use, Eli Lilly / FDA
    7. Subcutaneous (SQ) injections, MedlinePlus, U.S. National Library of Medicine
    8. St Clair-Jones A et al. Understanding and minimising injection-site pain following subcutaneous administration of biologics: a narrative review. Rheumatol Ther 2020

    This guide is general information about GLP-1 medications, based on prescribing information and published research. It is not medical advice and does not replace your prescriber or pharmacist. If an injection site is spreading, warm, draining or accompanied by fever, contact your healthcare provider. If you have swelling of the face, lips, tongue or throat or trouble breathing, call 911.

    Published by the Pep AI team · Updated September 2026